Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Net Margin: 2009-2025

Historic Net Margin for UNITED THERAPEUTICS (UTHR) over the last 17 years, with Sep 2025 value amounting to 42.36%.

  • UNITED THERAPEUTICS's Net Margin rose 109.00% to 42.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 53.33%, marking a year-over-year increase of 1302.00%. This contributed to the annual value of 41.53% for FY2024, which is 78.00% down from last year.
  • UNITED THERAPEUTICS's Net Margin amounted to 42.36% in Q3 2025, which was up 9.31% from 38.76% recorded in Q2 2025.
  • UNITED THERAPEUTICS's 5-year Net Margin high stood at 51.94% for Q1 2022, and its period low was -3,813.92% during Q4 2024.
  • Moreover, its 3-year median value for Net Margin was 41.27% (2024), whereas its average is -308.78%.
  • Per our database at Business Quant, UNITED THERAPEUTICS's Net Margin surged by 4,447bps in 2022 and then plummeted by 384,924bps in 2024.
  • Over the past 5 years, UNITED THERAPEUTICS's Net Margin (Quarterly) stood at 27.02% in 2021, then declined by 15bps to 26.88% in 2022, then surged by 844bps to 35.32% in 2023, then plummeted by 384,924bps to -3,813.92% in 2024, then spiked by 109bps to 42.36% in 2025.
  • Its Net Margin stands at 42.36% for Q3 2025, versus 38.76% for Q2 2025 and 40.56% for Q1 2025.